Seyffert, J. and Steffes, W. 2019. Vitiligo following alemtuzumab therapy in multiple sclerosis: a demonstration of secondary autoimmunity. International Journal of Research in Dermatology. 5, 4 (Oct. 2019), 882–884. DOI:https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20194687.